ONCO

ONCO

USD

Onconetix Inc. Common Stock

$3.060-0.110 (-3.470%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$3.170

Máximo

$3.170

Mínimo

$3.060

Volumen

0.01M

Fundamentos de la Empresa

Capitalización de Mercado

4.8M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.14M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $2.45Actual $3.060Máximo $251.6

Noticias Relacionadas

PR Newswire

Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms

Equity InsiderNews Commentary – Major pharmaceutical companies presenting at the European Society for Medical Oncology Congress October 17-21[1] are...

Ver más
Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms
GlobeNewswire

Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

CINCINNATI, OH, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc.

Ver más
Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.
GlobeNewswire

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

CINCINNATI, OH & FORT LEE, NJ, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc.

Ver más
Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.